The Global Health Body Sounds Concern Over Critical Lack of Obesity Medications
Less than a tenth of patients eligible to benefit from obesity jabs like Wegovy can access them, warns the global health agency as it releases its initial advice on the therapies.
Considering in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is calling for increased and just access to these injectable treatments.
Based on projections, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.
"The latest guidance recognises that excess weight is a lifelong illness that can be treated with holistic and lifelong support," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are key barriers to widespread access to the jabs that can aid individuals in losing significant weight, notes the body.
Weight-Loss Drug Scarcity
Despite the present most favorable scenario, the manufacturing of these medications could only cover approximately 100 million people – under 10% of those who need them, as stated by the health organization.
The advice encourages governments and firms to widen access, by approaches like licensing agreements.
A patent on semaglutide – the core ingredient of the drug Wegovy – is scheduled to end in several nations in 2026.
The Way Obesity Injections Operate
The injections imitate a biological compound to delay gastric emptying, suppress the appetite and boost the sense of being full so individuals eat less.
People usually see weight reduction after several weeks of starting on the regular doses.
Research points to patients may put most of the weight back on after a year of stopping the treatment, as their typical food cravings come back.
To be carrying excess weight elevates your chance for developing diseases, including diabetes, heart disease, stroke, and some cancers.
Obesity concerns people in all nations and was linked to millions of fatalities worldwide in 2024, according to the WHO.
